These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 35047242)

  • 21. Current cannabis-related situation in the Asia-Pacific region.
    Areesantichai C; Perngparn U; Pilley C
    Curr Opin Psychiatry; 2020 Jul; 33(4):352-359. PubMed ID: 32459704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial and Ethnic Differences in Cannabis Use Following Legalization in US States With Medical Cannabis Laws.
    Martins SS; Segura LE; Levy NS; Mauro PM; Mauro CM; Philbin MM; Hasin DS
    JAMA Netw Open; 2021 Sep; 4(9):e2127002. PubMed ID: 34570205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review.
    Manthey J; Jacobsen B; Hayer T; Kalke J; López-Pelayo H; Pons-Cabrera MT; Verthein U; Rosenkranz M
    Int J Drug Policy; 2023 Jun; 116():104039. PubMed ID: 37126997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seeking safety: a focus group study of young adults' cannabis-related attitudes, and behavior in a state with legalized recreational cannabis.
    Amroussia N; Watanabe M; Pearson JL
    Harm Reduct J; 2020 Nov; 17(1):92. PubMed ID: 33243280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis flower prices and transitions to legal sources after legalization in Canada, 2019-2020.
    Wadsworth E; Driezen P; Pacula RL; Hammond D
    Drug Alcohol Depend; 2022 Feb; 231():109262. PubMed ID: 34998249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attitudes Toward Medical Cannabis Legalization Among Serbian Medical Students.
    Vujcic I; Pavlovic A; Dubljanin E; Maksimovic J; Nikolic A; Sipetic-Grujicic S
    Subst Use Misuse; 2017 Jul; 52(9):1225-1231. PubMed ID: 28605305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personal Correlates of Support for Medical and Recreational Cannabis Legalization in Australia.
    Chiu V; Chan G; Hall W; Hides L; Lim C; Leung J
    Front Psychiatry; 2021; 12():551661. PubMed ID: 33716801
    [No Abstract]   [Full Text] [Related]  

  • 28. Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study.
    Wadsworth E; Rynard V; Driezen P; Freeman TP; Rychert M; Wilkins C; Hall W; Gabrys R; Hammond D
    Harm Reduct J; 2023 Feb; 20(1):19. PubMed ID: 36803833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use: A Longitudinal Study of Community Adults in Ontario.
    AminiLari M; Busse JW; Turna J; MacKillop J
    Cannabis Cannabinoid Res; 2023 Dec; 8(6):1133-1139. PubMed ID: 35333612
    [No Abstract]   [Full Text] [Related]  

  • 30. Perceived access to cannabis and ease of purchasing cannabis in retail stores in Canada immediately before and one year after legalization.
    Wadsworth E; Driezen P; Chan G; Hall W; Hammond D
    Am J Drug Alcohol Abuse; 2022 Mar; 48(2):195-205. PubMed ID: 35157544
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of highly-potent cannabis concentrate products: More common in U.S. states with recreational or medical cannabis laws.
    Hasin DS; Borodovsky J; Shmulewitz D; Walsh C; Livne O; Struble CA; Aharonovich E; Fink DS; Budney A
    Drug Alcohol Depend; 2021 Dec; 229(Pt B):109159. PubMed ID: 34844095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.
    Leung J; Chan G; Stjepanović D; Chung JYC; Hall W; Hammond D
    Psychopharmacology (Berl); 2022 May; 239(5):1509-1519. PubMed ID: 35020045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Home cultivation across Canadian provinces after cannabis legalization.
    Wadsworth E; Cristiano N; Pacheco K; Jesseman R; Hammond D
    Addict Behav Rep; 2022 Jun; 15():100423. PubMed ID: 35434251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marijuana legalization and opioid deaths.
    Mathur NK; Ruhm CJ
    J Health Econ; 2023 Mar; 88():102728. PubMed ID: 36808015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recreational Cannabis Use: Regulatory Aspects, Public Opinion and Concerns for Public Health.
    Scopetti M; Padovano M; Peruch M; Concato M; Livieri T; Radaelli D; D'Errico S
    Curr Pharm Biotechnol; 2023; 24(6):728-740. PubMed ID: 35996264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A difference-in-difference approach to examining the impact of cannabis legalization on disparities in the use of cigarettes and cannabis in the United States, 2004-17.
    Weinberger AH; Wyka K; Kim JH; Smart R; Mangold M; Schanzer E; Wu M; Goodwin RD
    Addiction; 2022 Jun; 117(6):1768-1777. PubMed ID: 34985165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of recreational cannabis dispensaries' availability, storefront signage and health benefit signs with cannabis use: findings from a representative adult sample in California, United States.
    Han B; Shi Y
    Addiction; 2023 Jul; 118(7):1270-1279. PubMed ID: 36680550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of the 4/20 cannabis holiday and adult-use cannabis legalization on medical cannabis sales and medical cannabis patient registration in Arizona.
    Meier MH; Meier MA; Anderson SF; Schaffer AL; Waddell JT; Roman BA; Poling SL; Barton EA
    Int J Drug Policy; 2023 Apr; 114():103974. PubMed ID: 36854217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The supply-side effects of cannabis legalization.
    Han J; Ng'ombe JN
    J Cannabis Res; 2022 Jul; 4(1):40. PubMed ID: 35864509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are recreational cannabis laws associated with declining medical cannabis program enrollment in the U.S.? An analysis of cardholder enrollment and demographic characteristics from 2013 to 2020.
    Okey SA; Castro SA; Waddell JT; Jones CB; Blake AJ; O'Rourke HP; Davis MC; Meier MH
    Int J Drug Policy; 2022 Feb; 100():103531. PubMed ID: 34818602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.